Demand for GLP-1s remains sky high. But what is the demand for programs that support the lifestyle modifications that need to accompany anti-obesity medications? More specifically, is there a demand for a virtual care program created specifically for people taking GLP-1s for weight health? You can’t answer these questions unless you create a program with these members and their unique needs in mind.
Here, the Omada Insights Lab analyzed member engagement, behavior, and outcomes in a specifically designed Enhanced GLP-1 Care Track. When looking at members taking a GLP-1 for weight health or cardiovascular risk reduction these findings indicate that:
Download the full white paper to learn more.